Please assess the completion status of the following clinical trial:

Trial Title: Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 18+~* Existing full face mask user or a nasal mask user~* Prescribed NIV therapy for at least 3 months~Exclusion Criteria:~* Inability to give informed consent~* Pregnant or think they may be pregnant~* Anatomical or physiological conditions making NIVtherapy inappropriate~* Patients who are in a coma or decreased level of consciousness~* Existing Simplus and Eson users

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Full face/Nasal masks (Type: EXPERIMENTAL): Simplus/Eson

Based on this trial design, predict the completion outcome and termination type (if applicable).